Search

107 Result(s)
Sort by

COVID-19: Research Update

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Commits to Thoracic Society’s COVID-19 Fund

Commits to Thoracic Society’s COVID-19 Fund

Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
COVID-19 France Support to Pasteur Institute

COVID-19 France Support to Pasteur Institute

As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
COVID-19 Once a nurse always a nurse

COVID-19 Once a nurse always a nurse

Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
COVID-19 Joining forces against COVID-19

COVID-19 Joining forces against COVID-19

While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
COVID-19 Protecting Our Employees

COVID-19 Protecting Our Employees

We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
COVID-19 Relief Efforts in China

COVID-19 Relief Efforts in China

Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
COVID-19 Germany Together through the Pandemic

COVID-19 Germany Together through the Pandemic

Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
COVID-19 Spain pulse oximeters donation

COVID-19 Spain pulse oximeters donation

Boehringer Ingelheim Spain has contributed to the COVIDALARM project by financing the purchase of 200 intelligent pulse oximeters. Learn more here.
COVID-19: EFPIA Industry Information

COVID-19: EFPIA Industry Information

The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Stroke, Don’t Stay at Home

Stroke, Don’t Stay at Home

During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
COVID-19 Volunteering in India

COVID-19 Volunteering in India

Learn about our employees in India volunteering during COVID-19, including Rashmi Suvarna, Head of Procurement at Boehringer Ingelheim India.
Healthcare professionals

Healthcare professionals

Faced with COVID-19, everyone has to adjust their lives, which can be challenging. This is especially true for healthcare professionals. Find out more.
COVID-19 IMI2–Call 21

COVID-19 IMI2–Call 21

CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
COVID-19 Q&A for people with diabetes

COVID-19 Q&A for people with diabetes

Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.